These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15891263)

  • 1. A one-year comparison of cost and outcomes of angioplasty in stent and nonstent patients.
    Sen SS; Khandker RK; Roth DA; Thomas J
    Am J Ther; 2005; 12(3):210-7. PubMed ID: 15891263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative cost comparison of treatments for coronary artery disease: the First Year Follow-Up of MASS II Study.
    Favarato D; Hueb W; Gersh BJ; Soares PR; Cesar LA; da Luz PL; Oliveira SA; Ramires JA;
    Circulation; 2003 Sep; 108 Suppl 1():II21-3. PubMed ID: 12970202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial).
    Greenberg D; Rosenfield K; Garcia LA; Berezin RH; Lavelle T; Fogleman S; Cohen DJ
    J Vasc Interv Radiol; 2004 Oct; 15(10):1065-9. PubMed ID: 15466792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z; Mahoney EM; Spertus JA; Booth J; Nugara F; Kolm P; Stables RH; Weintraub WS
    Am Heart J; 2006 Dec; 152(6):1153-60. PubMed ID: 17161069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What aspects are inefficient concerning percutaneous coronary intervention in Japan?: International cost-effectiveness comparisons].
    Chino M; Sakamoto M; Sasaki T; Isshiki T
    J Cardiol; 2004 Sep; 44(3):85-92. PubMed ID: 15500158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A; Cosgrave J; Latib A; Colombo A
    Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the institutional volume-outcome relations for balloon angioplasty and stenting in the stent era in California.
    Brown DL
    Am Heart J; 2003 Dec; 146(6):1071-6. PubMed ID: 14661001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 13-year follow-up of the German angioplasty bypass surgery investigation.
    Kaehler J; Koester R; Billmann W; Schroeder C; Rupprecht HJ; Ischinger T; Jahns R; Vogt A; Lampen M; Hoffmann R; Riessen R; Berger J; Meinertz T; Hamm CW
    Eur Heart J; 2005 Oct; 26(20):2148-53. PubMed ID: 15975991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
    Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J
    J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.
    Elezi S; Dibra A; Folkerts U; Mehilli J; Heigl S; Schömig A; Kastrati A
    J Am Coll Cardiol; 2006 Jul; 48(2):262-7. PubMed ID: 16843172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differences in in-hospital charge for percutaneous transluminal coronary angioplasty with and without the use of coronary stent].
    Ui S; Chino M; Suzuki M; Niwa A; Sasaki T; Yokozuka H
    J Cardiol; 1998 Nov; 32(5):315-21. PubMed ID: 9864688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft.
    Farraj N; Srivastava A; Pershad A
    J Invasive Cardiol; 2009 Jun; 21(6):278-81. PubMed ID: 19494404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
    Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
    Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of the unrestricted use of sirolimus-eluting stents vs. bare metal stents at 1 and 2-year follow-up: results from the RESEARCH Registry.
    Ong AT; Daemen J; van Hout BA; Lemos PA; Bosch JL; van Domburg RT; Serruys PW
    Eur Heart J; 2006 Dec; 27(24):2996-3003. PubMed ID: 17114234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.